Sign In
Buy FLGT
$18.14
-0.560 (-2.99%)
At Close: Jun 03, 2026
FULGENT GENETIC (FLGT) Moves 8% Higher: Will This Strength Last?
07:35am, Monday, 08'th Mar 2021
FULGENT GENETIC (FLGT) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near t
Can Fulgent Genetics Stock Rebound?
08:27am, Sunday, 07'th Mar 2021
New COVID-19 tests catapulted this company to fame, but investors are worried about what happens next.
Why Fulgent Genetics Stock Temporarily Soared 31% Today
11:13am, Friday, 05'th Mar 2021
Investors loved the company's fourth-quarter update but are concerned the growth could stall.
FLGT Stock: 3 Reasons Why Fulgent Genetics Is Soaring Today
09:24am, Friday, 05'th Mar 2021
Fulgent Genetics (FLGT) stock is on the rise in pre-market trading and we know exactly why investors are so happy with the company. The post FLGT Stock: 3 Reasons Why Fulgent Genetics Is Soaring Today
Fulgent Genetics to Participate in the Oppenheimer 31st Annual Healthcare Conference
08:00am, Friday, 05'th Mar 2021
TEMPLE CITY, Calif., March 05, 2021 (GLOBE NEWSWIRE) -- Fulgent Genetics, Inc. (NASDAQ: FLGT) (“Fulgent Genetics” or the “company”), a technology company providing comprehensive testing soluti
How Fulgent Genetics Wowed With Its Q4 Results
06:01am, Friday, 05'th Mar 2021
The genetic-testing company is firing on all cylinders.
FULGENT GENETIC (FLGT) Beats Q4 Earnings and Revenue Estimates
08:28pm, Thursday, 04'th Mar 2021
FULGENT GENETIC (FLGT) delivered earnings and revenue surprises of 40.59% and 30.77%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the stock?
Fulgent Genetics, Inc. (FLGT) CEO Ming Hsieh on Q4 2020 Results - Earnings Call Transcript
07:48pm, Thursday, 04'th Mar 2021
Fulgent Genetics, Inc. (FLGT) CEO Ming Hsieh on Q4 2020 Results - Earnings Call Transcript
These 2 Stocks Are Soaring Despite Another Market Plunge
05:40pm, Thursday, 04'th Mar 2021
Strong earnings sent both of these healthcare stocks higher after hours on Thursday.
Recap: Fulgent Genetics Q4 Earnings
04:58pm, Thursday, 04'th Mar 2021
Shares of Fulgent Genetics (NASDAQ:FLGT) moved higher by 24.0% in after-market trading after the company reported Q4 results. Quarterly Results Earnings per share were up 15400.00% year over year to $
Fulgent Genetics Reports Record Fourth Quarter and Full Year 2020 Financial Results
04:05pm, Thursday, 04'th Mar 2021
Fourth Quarter 2020 Results:
Better Buy: CRISPR vs. Fulgent Genetics
07:36am, Tuesday, 02'nd Mar 2021
These stocks made investors a lot of money in 2020. Which one will be the better choice this year?
Have $1,000? This Is the Best Coronavirus Stock to Buy Now
07:33am, Sunday, 28'th Feb 2021
Massive growth from COVID testing is hiding an excellent business.
What's the Strongest Buy: Moderna, Teladoc Health, or Fulgent Genetics?
02:00pm, Friday, 26'th Feb 2021
All three of these stocks have had incredible spikes because of COVID-19. One stock, however, is a safer and stronger long-term investment.
1 Green Flag for Fulgent Genetics
10:00am, Friday, 26'th Feb 2021
Here's why Fulgent stock is running so high.
